View Post

HudsonAlpha Foundation establishes neurological disease research fund

Huntsville, Ala. — The HudsonAlpha Foundation has established the Memory and Mobility (M&M) Fund for neurological disease research. The M&M fund will support HudsonAlpha Institute for Biotechnology’s current and future neurological disease research. The first project will be to sequence the genomes of 1,500 patients with Alzheimer and Alzheimer-related dementia. “We have an unprecedented opportunity to access this data set …

View Post

Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund

Financing to expand the Second Genome Microbiome Discovery Platform and accelerate the clinical development of pipeline programs  South San Francisco, Calif., April 20, 2016 – Second Genome, Inc., a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, today announced that it has closed an oversubscribed Series B investment round with $42.6 million in financing. The round was co-led …